Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and safety of telbivudine 600mg versus
adefovir dipivoxil 10mg in patients with compensated chronic hepatitis B.